Celestica Inc. (TSE:CLS – Get Free Report) (NYSE:CLS)’s share price reached a new 52-week high on Friday . The stock traded as high as C$140.43 and last traded at C$137.91, with a volume of 929145 shares trading hands. The stock had previously closed at C$129.42.
Wall Street Analyst Weigh In
A number of research analysts have recently weighed in on the company. Barclays raised Celestica to a “strong-buy” rating in a report on Tuesday, November 5th. UBS Group upgraded shares of Celestica to a “hold” rating in a report on Friday, November 22nd.
Get Our Latest Report on Celestica
Celestica Price Performance
Insider Activity
In related news, Director Leila Wong sold 600 shares of the firm’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of C$97.68, for a total transaction of C$58,605.18. Also, Director Alok K. Agrawal sold 1,550 shares of Celestica stock in a transaction on Monday, December 2nd. The shares were sold at an average price of C$119.54, for a total transaction of C$185,293.91. Insiders sold a total of 239,854 shares of company stock valued at $24,640,647 in the last quarter. 1.00% of the stock is currently owned by company insiders.
Celestica Company Profile
Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.
Further Reading
- Five stocks we like better than Celestica
- 5 Top Rated Dividend Stocks to Consider
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.